000292505 001__ 292505
000292505 005__ 20240906181514.0
000292505 0247_ $$2doi$$a10.1016/j.bbi.2024.08.023
000292505 0247_ $$2ISSN$$a0889-1591
000292505 0247_ $$2ISSN$$a1090-2139
000292505 037__ $$aDKFZ-2024-01751
000292505 082__ $$a150
000292505 1001_ $$aFazio, Luca$$b0
000292505 245__ $$aRetigabine, a potassium channel opener, restores thalamocortical neuron functionality in a murine model of autoimmune encephalomyelitis
000292505 260__ $$aOrlando, Fla.$$bAcademic Press$$c2024
000292505 3367_ $$2DRIVER$$aarticle
000292505 3367_ $$2DataCite$$aOutput Types/Journal article
000292505 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1725629820_31211
000292505 3367_ $$2BibTeX$$aARTICLE
000292505 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000292505 3367_ $$00$$2EndNote$$aJournal Article
000292505 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000292505 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000292505 7001_ $$aNaik, Venu Narayanan$$b1
000292505 7001_ $$aTherpurakal, Rajeevan Narayanan$$b2
000292505 7001_ $$aGomez Osorio, Fiorella M.$$b3
000292505 7001_ $$aRychlik, Nicole$$b4
000292505 7001_ $$0P:(DE-He78)39b28715a3581ccbfe6d3d91dd98ce26$$aLadewig, Julia$$b5
000292505 7001_ $$aStrüber, Michael$$b6
000292505 7001_ $$aCerina, Manuela$$b7
000292505 7001_ $$aMeuth, Sven G.$$b8
000292505 7001_ $$aBudde, Thomas$$b9
000292505 773__ $$0PERI:(DE-600)1462491-6$$a10.1016/j.bbi.2024.08.023$$gVol. 122, p. 202 - 215$$p202 - 215$$tBrain, behavior and immunity$$v122$$x0889-1591$$y2024
000292505 909CO $$ooai:inrepo02.dkfz.de:292505$$pVDB
000292505 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)39b28715a3581ccbfe6d3d91dd98ce26$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000292505 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000292505 9141_ $$y2024
000292505 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-21$$wger
000292505 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000292505 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000292505 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000292505 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000292505 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000292505 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000292505 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000292505 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-21
000292505 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000292505 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBRAIN BEHAV IMMUN : 2022$$d2023-10-21
000292505 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000292505 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000292505 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bBRAIN BEHAV IMMUN : 2022$$d2023-10-21
000292505 9201_ $$0I:(DE-He78)A340-20160331$$kA340$$lA340 NWG Engeneering von Zellidentitäten und Krankheitsmodellen$$x0
000292505 980__ $$ajournal
000292505 980__ $$aVDB
000292505 980__ $$aI:(DE-He78)A340-20160331
000292505 980__ $$aUNRESTRICTED